X4 Pharmaceuticals (XFOR) Revenue & Revenue Breakdown
X4 Pharmaceuticals Revenue Highlights
0
Latest Revenue (Q)
$560.00K
X4 Pharmaceuticals Revenue by Period
X4 Pharmaceuticals Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2021-12-31 | - | -100.00% |
2020-12-31 | $3.00M | 100.00% |
2019-12-31 | - | -100.00% |
2018-12-31 | $3.50M | 100.00% |
2017-12-31 | - | 100.00% |
2016-12-31 | - | 100.00% |
2015-12-31 | - | - |
X4 Pharmaceuticals Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-09-30 | $560.00K | -0.53% |
2024-06-30 | $563.00K | 100.00% |
2024-03-31 | - | -100.00% |
2023-12-31 | $3.06M | 100.00% |
2023-09-30 | - | 100.00% |
2023-06-30 | - | 100.00% |
2023-03-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2022-09-30 | - | 100.00% |
2022-06-30 | - | 100.00% |
2022-03-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2021-09-30 | - | 100.00% |
2021-06-30 | - | 100.00% |
2021-03-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2020-09-30 | - | 100.00% |
2020-06-30 | - | -100.00% |
2020-03-31 | $3.00M | 100.00% |
2019-12-31 | - | 100.00% |
2019-09-30 | - | 100.00% |
2019-06-30 | - | 100.00% |
2019-03-31 | - | -100.00% |
2018-12-31 | $3.50M | 100.00% |
2018-09-30 | - | 100.00% |
2018-06-30 | - | 100.00% |
2018-03-31 | - | 100.00% |
2017-12-31 | - | 100.00% |
2017-09-30 | - | 100.00% |
2017-06-30 | - | 100.00% |
2016-12-31 | - | - |
X4 Pharmaceuticals Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
HOOK | HOOKIPA Pharma | $20.13M | - |
MREO | Mereo BioPharma Group | $10.00M | - |
XFOR | X4 Pharmaceuticals | - | $560.00K |
PDSB | PDS Bio | - | - |
DAWN | Day One Biopharmaceuticals | - | $20.07M |
ABOS | Acumen Pharmaceuticals | - | - |
INZY | Inozyme Pharma | - | - |
ELEV | Elevation Oncology | - | - |
TERN | Terns Pharmaceuticals | - | - |
HEPA | Hepion Pharmaceuticals | - | - |
EFTR | eFFECTOR Therapeutics | - | - |